In fact, miR-16 has been reported to act as a tumor-suppressive miRNA in many cancer types [9–16], and multiple apoptosis-related genes are targeted by miR-16, including BCL-2, CCND1, CCND3, and CCNE1 [9, 13]. The gene discussed is BCL2; the disease is neoplasm.